clinical efficacy and safety of biodegradable magnesium needle patch
Not Applicable
Completed
- Conditions
- Diseases of the skin and subcutaneous tissue
- Registration Number
- KCT0007663
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 19
Inclusion Criteria
Patients with mild to moderate acne and between the ages of 20 to 40 years who were not taking any anti-acne oral medication
Exclusion Criteria
Patients who were taking any oral medication for acne treatment
Patients who were treated with botulinum toxin, HIFU, or lasers within 6 months before screening
Patients who underwent HA filler treatment within 1 year before screening
Patients who have plans for filler, laser, skin resurfacing, fat transplantation during the study period
Patients who are on any medications or disease which may influence the results using Mg
Women who were pregnant or lactating
Patients who do not agree with the contraception during the study period (12 weeks)
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method acne score/
- Secondary Outcome Measures
Name Time Method pore size.sebum secretion/porphyrin level